Hutchmed (China) Limited 11 January 2024 Press Release HUTCHMED Announces NDA Acceptance in China for Sovleplenib for the Treatment of Primary Immune Thrombocytopenia with Priority Review Status...
Hutchmed (China) Limited 29 December 2023 Blocklisting Six Monthly Return Hong Kong, Shanghai, & Florham Park, NJ - Friday, December 29, 2023: HUTCHMED (China) Limited (" HUTCHMED "...
Hutchmed (China) Limited 29 December 2023 Total Voting Rights Hong Kong, Shanghai, & Florham Park, NJ -- Friday, December 29, 2023: HUTCHMED (China) Limited ("HUTCHMED"...
Hutchmed (China) Limited 21 December 2023 Overseas Regulatory Announcement - Continuing Connected Transactions HUTCHMED (China) Limited (" HUTCHMED ") notes the below text, which is...
Hutchmed (China) Limited 13 December 2023 Press Release HUTCHMED Announces Continued Inclusion of ELUNATE(R) (fruquintinib) and SULANDA(R) (surufatinib) in the National Reimbursement Drug List in...
Hutchmed (China) Limited 07 December 2023 Overseas Regulatory Announcement - Disposal of Interest in Consumer Products Businesses HUTCHMED (China) Limited ("HUTCHMED") notes the below...
Hutchmed (China) Limited 01 December 2023 Press Release HUTCHMED Highlights Clinical Data to be Presented at 2023 ESMO Asia and ESMO Immuno-Oncology Congresses Hong Kong, Shanghai & Florham...
Hutchmed (China) Limited 30 November 2023 Total Voting Rights Hong Kong, Shanghai, & Florham Park, NJ -- Thursday, November 30, 2023: HUTCHMED (China) Limited ("HUTCHMED"...
Hutchmed (China) Limited 09 November 2023 HUTCHMED Announces that Takeda Receives U.S. FDA Approval of FRUZAQLA(TM) (fruquintinib) for Previously Treated Metastatic Colorectal Cancer - FRUZAQLA...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 33.29 | 33.29 | 33.29 | 44 | 33.29 | DE |
4 | 0 | 0 | 33.29 | 33.29 | 33.29 | 487 | 33.29 | DE |
12 | 0 | 0 | 33.29 | 33.29 | 33.29 | 261 | 33.29 | DE |
26 | 0 | 0 | 33.29 | 33.29 | 33.29 | 286 | 33.29 | DE |
52 | 0 | 0 | 33.29 | 33.29 | 33.29 | 299 | 33.29 | DE |
156 | 0 | 0 | 33.29 | 33.29 | 33.29 | 700 | 33.29 | DE |
260 | 0 | 0 | 33.29 | 33.29 | 33.29 | 617 | 33.29 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.